Relmada Therapeutics Inc —— 财务报表 (NASDAQ:RLMD) | MetaTrader

展开完整图表

新闻

Does Relmada Therapeutics (RLMD) Have the Potential to Rally 75.58% as Wall Street Analysts Expect?

Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD)

Relmada Therapeutics, Inc. (RLMD) Q4 2025 Earnings Call Transcript

瑞穗重申Relmada股票评级,癌症试验数据积极

Mizuho reiterates Relmada stock rating on positive cancer trial data

RLMD Stock Surges 42% in a Week: Here's What You Should Know

Avago, Lumentum among market cap stock movers on Monday

Tesla and Facebook among market cap stock movers on Monday

瑞穗维持Relmada股票评级,基于膀胱癌试验数据

Mizuho reiterates Relmada stock rating on bladder cancer trial data

Hims & Hers shares soar premarket; Pfizer, Agilent Technologies slip

Hims & Hers股价盘前飙升;辉瑞制药、安捷伦科技下跌